Sorry, you need to enable JavaScript to visit this website.
Skip to main content
WHITEPAPERS

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
CT -  Taipei City
CT -  Taipei City
TH -  Bangkok
NZ -  New Zealand
KR -  Seoul (Gangnam)
KR -  Gyeonggi-do
KR -  Seoul City Airport

North America

US -  Boston
US -  South Carolina

GLOBAL

English

CAREERS

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
CT -  Taipei City
CT -  Taipei City
TH -  Bangkok
NZ -  New Zealand
KR -  Seoul (Gangnam)
KR -  Gyeonggi-do
KR -  Seoul City Airport

North America

US -  Boston
US -  South Carolina

GLOBAL

English

The Benefits of Asia-Pacific Clinical Trials For Biotechs

 

There has been a continued shift of innovation from big pharma companies to biotechs, with the latter paving the ways for advancements in the life sciences industry. At the same pace, the Asia-Pacific (APAC) region has built a reputation as a hub for successful trials. There are unique benefits and challenges to conducting trials in this area, and partnerships with local expert contract research organizations (CROs) can help these companies take advantage of the opportunities. Informa Pharma Intelligence and Novotech surveyed respondents from biopharma companies across geographies to assess their clinical outsourcing needs and understanding of running trials in the APAC region.